B Liegl

Summary

Affiliation: Medical University of Graz
Country: Austria

Publications

  1. ncbi Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 49:576-81. 2006
  2. ncbi Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases
    B Liegl
    Department of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 50:439-47. 2007
  3. ncbi Androgen receptors are frequently expressed in mammary and extramammary Paget's disease
    Bernadette Liegl
    Department of Pathology, Medical University of Graz, Graz, Austria
    Mod Pathol 18:1283-8. 2005
  4. ncbi Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 50:448-52. 2007
  5. ncbi p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN)
    B Liegl
    Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria
    Histopathology 48:268-74. 2006
  6. ncbi Early vulvar lichen sclerosus: a histopathological challenge
    S Regauer
    Institute of Pathology, Working Groups of Dermatopathology and Gynaecopathology and Department of Gynaecology and Obstetrics, Medical University Graz, Graz, Austria sigrid
    Histopathology 47:340-7. 2005
  7. ncbi Vasculitis in lichen sclerosus: an under recognized feature?
    S Regauer
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 45:237-44. 2004
  8. ncbi Malignant transformation within benign adnexal skin tumours
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 45:162-70. 2004
  9. ncbi Primary cutaneous PEComa: distinctive clear cell lesions of skin
    Bernadette Liegl
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 32:608-14. 2008
  10. ncbi Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors
    Katherine A Janeway
    Department of Medicine, Children s Hospital Boston, MA, USA
    Cancer Res 67:9084-8. 2007

Collaborators

Detail Information

Publications13

  1. ncbi Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 49:576-81. 2006
    ..Therapy with Imatinib has been proposed as a therapeutic option, although in most reports desmoid tumours are reported to be c-kit-...
  2. ncbi Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases
    B Liegl
    Department of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 50:439-47. 2007
    ..The aim of this study was, by the use of immunohistochemistry, to derive further information about the cell(s) of origin, find a diagnostically useful immunohistochemical panel and investigate candidates for possible targeted therapy...
  3. ncbi Androgen receptors are frequently expressed in mammary and extramammary Paget's disease
    Bernadette Liegl
    Department of Pathology, Medical University of Graz, Graz, Austria
    Mod Pathol 18:1283-8. 2005
    ..The knowledge about frequent expression of AR in Paget's disease could lead to the development of a new adjuvant therapy, particularly in patients with recurrent disease...
  4. ncbi Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 50:448-52. 2007
    ....
  5. ncbi p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN)
    B Liegl
    Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria
    Histopathology 48:268-74. 2006
    ..CONCLUSION: d-VIN in LS is rare, while p53 staining is common and best explained as an ischaemic stress response due to poor oxygenation, vasculitis and inflammation rather than as a marker of a precancerous lesion in LS...
  6. ncbi Early vulvar lichen sclerosus: a histopathological challenge
    S Regauer
    Institute of Pathology, Working Groups of Dermatopathology and Gynaecopathology and Department of Gynaecology and Obstetrics, Medical University Graz, Graz, Austria sigrid
    Histopathology 47:340-7. 2005
    ..Recognition and treatment of these early stages of LS may result in longstanding remission. Progression to atrophic stages with their associated morbidity and even to squamous cell carcinoma may be prevented...
  7. ncbi Vasculitis in lichen sclerosus: an under recognized feature?
    S Regauer
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 45:237-44. 2004
    ..LS is a skin disease of presumed autoimmune origin. Autoimmune diseases are mediated by lymphocytes which occasionally produce a lymphocytic vasculitis...
  8. ncbi Malignant transformation within benign adnexal skin tumours
    B Liegl
    Institute of Pathology, Medical University of Graz, Graz, Austria
    Histopathology 45:162-70. 2004
    ..Therefore, patients with systemic diseases or malignancy should be carefully examined and followed for sudden changes in pre-existing benign cutaneous tumours...
  9. ncbi Primary cutaneous PEComa: distinctive clear cell lesions of skin
    Bernadette Liegl
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 32:608-14. 2008
    ..Primary cutaneous PEComas are rare and thus far apparently benign cutaneous tumors. Accurate recognition of this entity is essential because of potential misdiagnosis as malignant tumors, especially malignant melanoma...
  10. ncbi Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors
    Katherine A Janeway
    Department of Medicine, Children s Hospital Boston, MA, USA
    Cancer Res 67:9084-8. 2007
    ..KIT activation levels in pediatric KIT-wild-type GISTs are comparable with those in KIT-mutant GISTs. Therapies that inhibit KIT activation, or crucial KIT signaling intermediates, should be explored in pediatric KIT-wild-type GIST...
  11. ncbi Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin
    Haohai Liang
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Am J Surg Pathol 31:304-10. 2007
    ..Our results suggest that podoplanin can be a useful tool to distinguish primary skin adnexal carcinomas form adenocarcinomas metastatic to skin with high sensitivity (94.5%) and specificity (97.2%)...
  12. ncbi p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease
    Olaf Reich
    Department of Obstetrics and Gynecology, Medical University of Graz, Austria
    Mod Pathol 18:354-7. 2005
    ..All patients with scores 2 and 3 showed HER2 oncogene amplification. Overexpression of p185Her2 and HER2 oncogene amplification appears to be common in recurrent vulvar Paget's disease...
  13. ncbi Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations
    Bernadette Liegl
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 32:1080-7. 2008
    ..Recognition of this distinct entity is essential to avoid confusion with malignant tumors, especially in the gastrointestinal and upper respiratory tracts...